Your cart is empty
Browse supplements to get started.
In patients with chronic insomnia, DSIP (Delta Sleep-Inducing Peptide) administration increased slow-wave sleep (deep sleep) duration, normalized sleep architecture, and reduced cortisol dysregulation associated with chronic stress. Patients reported improved sleep quality and daytime functioning without the sedative hangover effects of conventional sleep medications.
DSIP is intriguing because it doesn't just knock you out—it appears to help restore natural sleep architecture, particularly deep sleep, which is where the body does most of its repair work. Unlike sedatives that force unconsciousness, DSIP seems to work by modulating stress hormones and supporting the body's own sleep-wake regulation. The cortisol normalization is particularly relevant because chronic stress and poor sleep create a vicious cycle: high cortisol disrupts sleep, poor sleep elevates cortisol. DSIP may help break that cycle. While the research is older and human data is limited by today's standards, the concept of a peptide that supports sleep regulation rather than forcing sedation remains compelling. The lack of next-day grogginess reported in studies suggests it's working with your biology, not overriding it.
DSIP was discovered in the 1970s and generated significant research interest in the 1980s and 1990s as a potential natural sleep regulator. The peptide was originally isolated from the brain and was shown to induce slow-wave sleep in rabbits, hence the name. However, DSIP's exact mechanism remained elusive, and research into it declined in Western countries as pharmaceutical sleep aids gained dominance. The peptide appears to work through multiple pathways including stress hormone modulation, endorphin regulation, and possibly direct effects on sleep centers in the hypothalamus. This 1988 study was among several showing effects in humans with sleep disorders. While DSIP never achieved mainstream pharmaceutical development, it remains used in research and clinical circles, particularly in Europe and Russia. The challenge with DSIP research is that most studies are older and relatively small, but the underlying concept—supporting endogenous sleep regulation rather than pharmacological sedation—aligns with modern understanding of sleep medicine.
The effects of DSIP on sleep, performance and cortisol levels in chronic insomnia
DSIP
The Deep Sleep Peptide
This is an educational summary of published research, not medical advice. Always consult a healthcare provider before starting any peptide protocol.